Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19

NCT04456361 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

ARDS, Human
Covid-19

Interventions

BIOLOGICAL: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords

Sponsor

Instituto de Medicina Regenerativa